Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.
History
Spin-off
On July 26, 2022, 3M announced that it would spin off its healthcare division as a separate company to streamline operations. The new company would assume 3M's business in wound and oral care, health informatics, and biopharmaceutical filtration.[2] The sales of products in these fields accounted for about a quarter of 3M's total sales in 2021.[3] CEO Mike Roman said that the split would "position 3M for the future, to create more opportunity and greater certainty".[4]
Bloomberg News noted that the move followed a period of declining profits attributed to shifting economic trends, and would "dramatically reshape a company known for diverse product lines, from electronic components to dental adhesives to Post-it notes".[5] In fact, the announcement of the spin-off occurred the same day as a separate announcement that a 3M subsidiary, Aearo Technologies, had declared Chapter 11 bankruptcy after settling lawsuits alleging that the earplugs it had manufactured for U.S. military service members were defective and damaged their hearing.[6]
Many observers placed this business decision in a larger trend of other industrial conglomerates that had undergone similar splits in the preceding few years. In November 2021, General Electric announced that it would spin off its health care, aerospace, and energy businesses as GE HealthCare, GE Aerospace, and GE Vernova, respectively;[5] the same week, Johnson & Johnson announced that it would spin off its consumer health division as a separate company, Kenvue.[4] Comparisons were also made to the decisions by Kellogg's[4] and Toshiba to split into multiple entities,[6] as well as United Technologies's spin-off of Otis Worldwide and Carrier Global before its merger with Raytheon.[5] 3M itself sold its food safety business to Neogen in September 2022.[2]
On January 24, 2023, the health care business was registered as a corporation in Delaware under the provisional name "3M Health Care Co.".[7] On November 16, 2023, 3M unveiled that the new company would be called Solventum, a portmanteau of the words "solving" and "momentum".[8]
The spin-off was completed on April 1, 2024, with 3M retaining about 19.9% of Solventum.[9]
On February 25, 2025, it was announced that Thermo Fisher Scientific would acquire the company's Purification & Filtration business unit for $4.1B.[10]
Independent operation
The first CEO of Solventum is Bryan Hanson,[8] who has served in the role since September 1, 2023.[11]
External links
References
- 2024 Annual Report (Form 10-K) U.S. Securities and Exchange Commission, February 28, 2025^
- Jack Stebbins. 3M will spin off its health-care business into a new public company CNBC, July 26, 2022, retrieved February 23, 2024^
- Nick Halter. What 3M's health care spinoff could mean for Minnesota Axios, July 27, 2022, retrieved February 23, 2024^
- Tim Nelson. 3M will spin off $8.6 billion health care business into new company Minnesota Public Radio, July 26, 2022, retrieved February 23, 2024^
- Ryan Beene, Catherine Larkin. 3M soars most since pandemic's start on health-care spinoff plan Bloomberg News, July 26, 2022, retrieved February 23, 2024^
- Kannaki Deka, Abhijith Ganapavaram. 3M to spin off healthcare business, earplugs unit seeks bankruptcy protection Reuters, July 26, 2022, retrieved February 23, 2024^
- Form 10, Exhibit 99.1 (Solventum Corporation) U.S. Securities and Exchange Commission, February 20, 2024, retrieved February 23, 2024^
- Brooks Johnson, Burl Gilyard. 3M reveals the name of its health care business to be spun off next year Star Tribune, November 16, 2023, retrieved February 23, 2024^
- Brooks Johnson. 3M's health care spinoff becomes Minnesota's newest public company on April 1 Star Tribune, February 21, 2024, retrieved February 23, 2024^
- Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B PR Newswire, February 25, 2025, retrieved February 25, 2025^
- Kannaki Deka. 3M names Bryan Hanson as CEO of its health care business Reuters, August 22, 2023, retrieved February 23, 2024^